Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Growth Stocks That Could Double in 2023

TheMotleyFool

0 0

2 Growth Stocks That Could Double in 2023: https://g.foolcdn.com/editorial/images/709470/patient-sitting-on-hospital-bed.jpg

Investing in biotech companies, especially relatively small ones, can be a double-edged sword. On the one hand, these stocks often carry massive upside potential, provided things work in their favor. However, this potential comes with elevated risks, so investors should always be cautious when considering investing in smaller companies in the industry.

With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics (NASDAQ: CRSP) and Bluebird Bio (NASDAQ: BLUE). These companies' ongoing developments could fuel huge runs in 2023.